恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
恒瑞医药(600276) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入599,753.392,281,978.471,701,363.221,116,837.90549,232.01
营业收入599,753.392,281,978.471,701,363.221,116,837.90549,232.01
二、营业总成本441,291.621,821,415.251,325,878.67872,880.61420,640.23
营业成本94,284.94352,524.78265,755.41176,937.2285,951.71
营业税金及附加5,801.7921,925.7116,273.3210,960.775,095.47
销售费用176,425.60757,717.59540,855.13367,844.60166,975.69
管理费用57,630.16241,697.45167,591.25108,392.0954,567.10
财务费用-14,863.55-47,838.99-37,145.93-24,382.12-6,833.69
研发费用122,012.69495,388.71372,549.50233,128.05114,883.95
资产减值损失----------
公允价值变动收益733.77-5,825.69-3,576.83-2,762.30-378.65
投资收益61.59-4,915.68-1,156.57-955.833,310.50
其中:对联营企业和合营企业的投资收益---7,269.60-4,711.47-4,180.45--
汇兑收益----------
三、营业利润163,600.88490,990.49394,132.95257,020.94134,443.01
加:营业外收入19.88379.84243.48161.3342.81
减:营业外支出13,369.6824,659.3613,138.745,937.752,010.95
其中:非流动资产处置损失----------
四、利润总额150,251.08466,710.97381,237.69251,244.52132,474.87
减:所得税费用13,502.2138,928.9036,134.7122,203.939,135.62
五、净利润136,748.87427,782.07345,102.98229,040.58123,339.25
归属于母公司所有者的净利润136,892.92430,243.59347,377.92230,826.50123,910.75
少数股东损益-144.06-2,461.52-2,274.93-1,785.92-571.50
六、每股收益
基本每股收益(元/股)0.21000.68000.55000.36000.1900
稀释每股收益(元/股)0.21000.68000.55000.36000.1900
七、其他综合收益-592.541,784.141,400.442,251.32-1,968.60
八、综合收益总额136,156.33429,566.21346,503.42231,291.90121,370.64
归属于母公司所有者的综合收益总额136,278.73431,853.01348,469.65232,700.91122,078.04
归属于少数股东的综合收益总额-122.40-2,286.79-1,966.24-1,409.01-707.39
下载全部历史数据到excel中 返回页顶